Rapid Antibody Tests (RATs)

March 2020 Reassessment

 

I. Assessment

A. Policy and Research Question

Policy Question:

Should the Philippine government introduce COVID-19 IgG and IgM RDT kits in detecting COVID19 cases among mild and asymptomatic at-risk cases versus no testing?

       Research Questions:

      1. What are the evidence-based guidelines for the use of COVID-19 IgG and IgM RDT kits among mild and asymptomatic at-risk cases? What are the current COVID-19 testing protocols among healthcare systems?
      2. What is the accuracy of COVID-19 IgG and IgM RDT kits in detecting COVID19 cases among mild and asymptomatic at-risk cases versus gold standard testing?
      3. Does COVID-19 IgG and IgM RDT kits represent value for money (in terms of cost per additional case detected) in detecting COVID19 among mild and asymptomatic at-risk cases versus no testing?

B. Protocol: Not available.

C. Reviewers: Health Technology Assessment Unit, DOH

D. Start of Review:  March 23, 2020

E. End of Review: March 25, 2020

II. Recommendation

Evidence summary:  https://bit.ly/ESRATsMarch2020

Rapid review: https://bit.ly/RRRATSMarch2020

III. Decision

Not available.